We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ACLX market cap is 2.83B. The company's latest EPS is USD -1.3389 and P/E is -40.00.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 17.91M | 14.3M | 14.96M |
| Operating Income | -86.21M | -40M | -30.46M | -29.56M | -44.86M |
| Net Income | -85.21M | -38.99M | -27.34M | -23.85M | -39.34M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 110.32M |
| Operating Income | -65.02M | -191.26M | -89.88M |
| Net Income | -64.97M | -188.68M | -70.69M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 337.33M | 313.82M | 622.94M | 623.53M | 614.22M |
| Total Liabilities | 101.04M | 108.86M | 319.23M | 329.86M | 348.09M |
| Total Equity | 236.28M | 204.95M | 303.72M | 293.67M | 266.13M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 128.78M | 313.82M | 825.13M |
| Total Liabilities | 16.92M | 108.86M | 339.75M |
| Total Equity | -121.52M | 204.95M | 485.38M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -71.78M | -99.3M | 182.04M | 159.43M | 149.33M |
| Investing | -151.3M | -117.67M | -66.77M | -15.5M | -175.53M |
| Financing | 251.31M | 252.63M | 95.45M | 95.56M | 90.57M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -54.24M | -99.3M | 207.57M |
| Investing | -79.98M | -117.67M | -154.51M |
| Financing | 118.45M | 252.63M | 279.16M |
| Market Cap | 2.83B |
| Price to Earnings Ratio | -40.00 |
| Price to Sales Ratio | 25.63 |
| Price to Cash Ratio | 7.17 |
| Price to Book Ratio | 5.82 |
| Dividend Yield | - |
| Shares Outstanding | 52.8M |
| Average Volume (1 week) | 484.98k |
| Average Volume (1 Month) | 427.5k |
| 52 Week Change | 53.70% |
| 52 Week High | 75.10 |
| 52 Week Low | 30.74 |
| Spread (Intraday) | 10 (16.67%) |
| Company Name | Arcellx Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.arcellx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
